Breast Cancer Trials

Breast Cancer Trials World-leading breast cancer clinical trials research based in Australia and New Zealand.

Clinical trials are the essential tool which proves that a new treatment or prevention strategy is effective and safe before it is made widely available to women with breast cancer or who are at risk. 56 women are diagnosed with breast cancer in Australia and New Zealand every day. Each of these women can receive a treatment which has been through the rigorous clinical trials research process and

today, they are more likely to survive longer and free of breast cancer than at any other time in history.

Happy World Environment Day 🌏At Breast Cancer Trials, while our focus is improving outcomes for people with breast cance...
04/06/2026

Happy World Environment Day 🌏

At Breast Cancer Trials, while our focus is improving outcomes for people with breast cancer, we also believe in creating a healthier future for generations to come.

From reducing waste to using renewable energy and supporting ethical supply chains, we’re committed to doing our part to take πŸ’š

Looking for some GOOD news?We're taking a moment to celebrate the wins - big and small - at Breast Cancer Trials. From r...
04/06/2026

Looking for some GOOD news?

We're taking a moment to celebrate the wins - big and small - at Breast Cancer Trials. From research breakthroughs to personal milestones, volunteer anniversaries, and everything in between, here are five reasons to feel hopeful from the past month. πŸ’—

Now we'd love to hear from you!

What's your good news? It could be a treatment milestone, a personal achievement, a special moment with loved ones, or simply something that made you smile this week.

Share your good news in the comments below and let's celebrate together. πŸ‘‡

We just had to share this.πŸ’•When Natalie was diagnosed with triple negative breast cancer, her son Jude was only six year...
03/06/2026

We just had to share this.πŸ’•

When Natalie was diagnosed with triple negative breast cancer, her son Jude was only six years old. Like many parents, she hoped he was too young to fully understand what was happening.

But years later, in Year 4, Jude was asked to write about his "Pivotal Moment". At just 10 years old, he chose to write about his mum's breast cancer diagnosis and treatment.

His words are a powerful reminder that breast cancer affects entire families, not just the person diagnosed. ❀️

Having faced breast cancer twice, 20 years apart, Natalie's second diagnosis was triple negative breast cancer - an aggressive form of the disease with fewer treatment options available.

This tax time, we're aiming to raise $505,000 by 30 June to support the OPT-Pembro clinical trial.

The trial will investigate whether some people with triple negative breast cancer can safely receive less treatment while achieving the same outcomes - helping to reduce the long-term impact of treatment while maintaining its effectiveness.

Every donation brings us closer to better, kinder treatment options for people diagnosed with breast cancer.

Donate today and help fund life-changing research. πŸ’— https://bct.org.au/tax26

πŸ’— New results from the CAPTURE clinical trial have been presented at  .The study investigated whether a new targeted tre...
02/06/2026

πŸ’— New results from the CAPTURE clinical trial have been presented at .

The study investigated whether a new targeted treatment could improve outcomes for people with hormone receptor-positive metastatic breast cancer.

While the new treatment was not shown to be more effective than the current standard treatment with capecitabine, the results confirmed that capecitabine remains a highly effective and well-tolerated option for many patients.

The trial also demonstrated the potential of liquid biopsy blood tests to help guide more personalised treatment approaches in the future.

Congratulations to Professor Sarah-Jane Dawson and everyone involved in this important research.

Learn more: https://www.breastcancertrials.org.au/media-releases/capture-trial-delivers-learnings-for-metastatic-breast-cancer-treatment/

Do you know your breast cancer risk?iPrevent is an evidence-based online tool designed to help women better understand t...
01/06/2026

Do you know your breast cancer risk?

iPrevent is an evidence-based online tool designed to help women better understand their individual breast cancer risk and learn what actions may help reduce it.

The tool also provides tailored information about lifestyle factors and breast cancer screening.

πŸ‘‰ Learn more: https://www.breastcancertrials.org.au/breast-cancer-resources/iprevent/

πŸ’— Great news for people diagnosed with early breast cancer!Results from the OPTIMA clinical trial were presented at the ...
31/05/2026

πŸ’— Great news for people diagnosed with early breast cancer!

Results from the OPTIMA clinical trial were presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago yesterday.

The study found that many patients aged 40 and over with a low Prosigna genetic test score can safely avoid chemotherapy without increasing their risk of the cancer returning.

This means thousands of people each year may be able to avoid the physical and emotional side effects of chemotherapy while still receiving effective treatment.

Congratulations to Study Chair, Associate Professor Belinda Kiely, and to everyone involved in this important research.

πŸ‘‰ Learn more: https://www.youtube.com/watch?v=7lT9YwDikK8

Not all breast cancers are the same. Triple negative breast cancer is one of the most aggressive forms and one of the ha...
27/05/2026

Not all breast cancers are the same.

Triple negative breast cancer is one of the most aggressive forms and one of the hardest to treat. It accounts for around 15% of breast cancer diagnoses yet has fewer targeted treatment options than other types.

For many women, treatment can mean chemotherapy, surgery, and a full year of immunotherapy.

Researchers like Dr Julie Dixon-Douglas are now working on a clinical trial that could help some women safely avoid months of extra treatment and its side effects - without compromising survival.

β€œOPT-Pembro could help reduce the amount of treatment and associated side effects – all without compromising patient outcomes.

It would mean some women with triple negative breast cancer could get back to their lives and families sooner.”

That’s why funding research like OPT-Pembro matters so much. πŸ’—

Because surviving breast cancer shouldn’t take more of a lasting toll than it has to.

Please donate today - https://bct.org.au/tax26

National Reconciliation Week is an opportunity for all Australians to deepen their understanding of our shared histories...
26/05/2026

National Reconciliation Week is an opportunity for all Australians to deepen their understanding of our shared histories, cultures and achievements, while reflecting on the role each of us can play in advancing reconciliation across Australia.

Historically, there has been under-representation of Indigenous communities in clinical trials research. First Nations Australians tend to experience poorer health outcomes in breast cancer, with Indigenous women 1.2 times more likely to die from this disease compared to the wider population.

In addition, the five-year relative survival rate for Aboriginal and Torres Strait Islander peoples is lower at 81%, compared to 90% in the general Australian population.

We have a number of dedicated resources on our website, including information on the ReViTALISE Project, which all aim to increase access to clinical trials among Aboriginal and Torres Strait Islander people.

Visit our website to learn more: https://www.breastcancertrials.org.au/breast-cancer-resources/translated-brochures/

New research is exploring how advanced imaging can improve breast cancer diagnosis πŸ’—In the fifth year of our clinical fe...
25/05/2026

New research is exploring how advanced imaging can improve breast cancer diagnosis πŸ’—

In the fifth year of our clinical fellowship program, Dr Caroline MacCallum is conducting a project that will evaluate how combining 'contrast-enhanced mammography' (CEM) and Magnetic Resonance Imaging (MRI) may improve diagnostic accuracy in early breast cancer.

The findings could help inform treatment decisions and improve long-term outcomes.

Learn more: https://www.youtube.com/watch?v=znEhuZewpeM&t=2s

Address

Level 4, 175 Scott Street
Newcastle, NSW
2300

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+611800423444

Alerts

Be the first to know and let us send you an email when Breast Cancer Trials posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Breast Cancer Trials:

Share